Leukemia, 2021-01, Vol.35 (1), p.235-238
- Gentile, Massimo
- Morabito, Fortunato
- Del Poeta, Giovanni
- Mauro, Francesca Romana
- Reda, Gianluigi
- Sportoletti, Paolo
- Laurenti, Luca
- Coscia, Marta
- Herishanu, Yair
- Recchia, Anna Grazia
- Varettoni, Marzia
- Murru, Roberta
- Chiarenza, Annalisa
- Condoluci, Adalgisa
- Moia, Riccardo
- Pietrasanta, Daniela
- Loseto, Giacomo
- Consoli, Ugo
- Scortechini, Ilaria
- Rossi, Francesca Maria
- Zucchetto, Antonella
- Fraticelli, Vincenzo
- Vigna, Ernesto
- Botta, Cirino
- Tripepi, Giovanni
- Arrigo, Graziella D’
- Rago, Angela
- Angeletti, Ilaria
- Biagi, Annalisa
- Del Giudice, Ilaria
- Bomben, Riccardo
- Rigolin, Gian Matteo
- Rossi, Davide
- Di Raimondo, Francesco
- Gaidano, Gianluca
- Polliack, Aaron
- Cuneo, Antonio
- Foà, Robin
- Gattei, Valter
2021
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Gentile, Massimo
- Morabito, Fortunato
- Del Poeta, Giovanni
- Mauro, Francesca Romana
- Reda, Gianluigi
- Sportoletti, Paolo
- Laurenti, Luca
- Coscia, Marta
- Herishanu, Yair
- Recchia, Anna Grazia
- Varettoni, Marzia
- Murru, Roberta
- Chiarenza, Annalisa
- Condoluci, Adalgisa
- Moia, Riccardo
- Pietrasanta, Daniela
- Loseto, Giacomo
- Consoli, Ugo
- Scortechini, Ilaria
- Rossi, Francesca Maria
- Zucchetto, Antonella
- Fraticelli, Vincenzo
- Vigna, Ernesto
- Botta, Cirino
- Tripepi, Giovanni
- Arrigo, Graziella D’
- Rago, Angela
- Angeletti, Ilaria
- Biagi, Annalisa
- Del Giudice, Ilaria
- Bomben, Riccardo
- Rigolin, Gian Matteo
- Rossi, Davide
- Di Raimondo, Francesco
- Gaidano, Gianluca
- Polliack, Aaron
- Cuneo, Antonio
- Foà, Robin
- Gattei, Valter
- Titel
- Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study
- Ist Teil von
- Leukemia, 2021-01, Vol.35 (1), p.235-238
- Ort / Verlag
- London: Nature Publishing Group UK
- Erscheinungsjahr
- 2021
- Quelle
- MEDLINE
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0887-6924eISSN: 1476-5551DOI: 10.1038/s41375-020-0833-xTitel-ID: cdi_proquest_journals_2475612421
- Format
- –
- Schlagworte
- 692/499, 692/699/1541/1990/283/1895, Adenine - administration & dosage, Adenine - adverse effects, Adenine - analogs & derivatives, Adenine - therapeutic use, Anemia, Antineoplastic Agents, Immunological - administration & dosage, Antineoplastic Agents, Immunological - adverse effects, Antineoplastic Agents, Immunological - therapeutic use, Cancer Research, Chronic lymphocytic leukemia, Clinical medicine, Clinical trials, Critical Care Medicine, Development and progression, Drug therapy, Drugs, Evaluation, Hematology, Hemoglobin, Humans, Immunotherapy, Inhibitor drugs, Intensive, Internal Medicine, Letter, Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis, Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy, Leukemia, Lymphocytic, Chronic, B-Cell - mortality, Lymphatic leukemia, Medicine, Medicine & Public Health, Molecular Targeted Therapy, Mortality, Multivariate analysis, Oncology, Piperidines - administration & dosage, Piperidines - adverse effects, Piperidines - therapeutic use, Prognosis, Protein Kinase Inhibitors - administration & dosage, Protein Kinase Inhibitors - adverse effects, Protein Kinase Inhibitors - therapeutic use, Targeted cancer therapy, Treatment Outcome